FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation
Device is for treatment of patients to reduce mitral regurgitation in certain patients with heart failure symptoms who fail to respond to traditional therapy
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Cardiology | Food and Drug Administration (FDA) | Gastroschisis Repair | Heart | Heart Failure | Heart Valve Surgery